The Genomic Answers for Children's Health Act of 2026 requires Medicaid to cover whole genome and whole exome sequencing tests for children suspected of having genetic disorders, rare diseases, or conditions of unknown origin, including congenital anomalies, developmental delays, and intellectual disabilities. The bill ensures that these genetic tests are paid for separately and are not bundled with other medical services, and requires that qualified healthcare providers can order them as first-line diagnostic tools. The legislation also directs the Department of Health and Human Services to conduct outreach to medical professionals, hospitals, and families to increase awareness of this coverage, and requires two government reports within two years to assess implementation, identify barriers to access like prior authorization delays, and make recommendations for improvement. The new coverage requirements take effect on January 1, 2027.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.